Evidence map›Paper›PMID 35383177›Full record

ArticleNature communications2022

Cryo-EM structures of a LptDE transporter in complex with Pro-macrobodies offer insight into lipopolysaccharide translocation.

Mathieu Botte, Dongchun Ni, Stephan Schenck, Iwan Zimmermann, Mohamed Chami, Nicolas Bocquet, Pascal Egloff, Denis Bucher, Matilde Trabuco, Robert K Y Cheng and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Hidden gems bring proteins into view.Nature chemical biology · 2026
    Article
  7. Article
  8. Small siphophage binding to an open state of the LptDE outer membrane lipopolysaccharide translocon.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Analysis ofmSphere · 2025
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Mathieu Botte *leadXpro AG, Park Innovaare, 5234, Villigen, Switzerland.
Dongchun Ni *C-CINA, Biozentrum, University of Basel, Mattenstr. 24, 4058, Basel, Switzerland.
Stephan Schenck *leadXpro AG, Park Innovaare, 5234, Villigen, Switzerland.
Iwan ZimmermannInstitute of Medical Microbiology, University of Zürich, Gloriastasse 28/30, 8006, Zürich, Switzerland.ORCID http://orcid.org/0000-0003-3476-4749
Mohamed ChamiC-CINA, Biozentrum, University of Basel, Mattenstr. 24, 4058, Basel, Switzerland.
Nicolas BocquetleadXpro AG, Park Innovaare, 5234, Villigen, Switzerland.
Pascal EgloffInstitute of Medical Microbiology, University of Zürich, Gloriastasse 28/30, 8006, Zürich, Switzerland.
Denis BucherleadXpro AG, Park Innovaare, 5234, Villigen, Switzerland.
Matilde TrabucoleadXpro AG, Park Innovaare, 5234, Villigen, Switzerland.ORCID http://orcid.org/0000-0001-9234-8685
Robert K Y ChengleadXpro AG, Park Innovaare, 5234, Villigen, Switzerland.
Janine D BrunnerLaboratory of Biomolecular Research, Division of Biology and Chemistry, Paul Scherrer Institute (PSI), 5232, Villigen, Switzerland.ORCID http://orcid.org/0000-0003-4237-9322
Markus A SeegerInstitute of Medical Microbiology, University of Zürich, Gloriastasse 28/30, 8006, Zürich, Switzerland.ORCID http://orcid.org/0000-0003-1761-8571
Henning StahlbergC-CINA, Biozentrum, University of Basel, Mattenstr. 24, 4058, Basel, Switzerland.ORCID http://orcid.org/0000-0002-1185-4592
Michael HennigleadXpro AG, Park Innovaare, 5234, Villigen, Switzerland. michael.hennig@leadxpro.com.ORCID http://orcid.org/0000-0002-1839-2351
University of Basel · CHUniversity of Zurich · CHExpro (United Kingdom) · GBPaul Scherrer Institute · CHVIB-VUB Center for Structural Biology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lipopolysaccharides are major constituents of the extracellular leaflet in the bacterial outer membrane and form an effective physical barrier for environmental threats and for antibiotics in Gram-negative bacteria. The last step of LPS insertion via the Lpt pathway is mediated by the LptD/E protein complex. Detailed insights into the architecture of LptDE transporter complexes have been derived from X-ray crystallography. However, no structure of a laterally open LptD transporter, a transient state that occurs during LPS release, is available to date. Here, we report a cryo-EM structure of a partially opened LptDE transporter in complex with rigid chaperones derived from nanobodies, at 3.4 Å resolution. In addition, a subset of particles allows to model a structure of a laterally fully opened LptDE complex. Our work offers insights into the mechanism of LPS insertion, provides a structural framework for the development of antibiotics targeting LptD and describes a highly rigid chaperone scaffold to enable structural biology of challenging protein targets.

Indexed as

Escherichia coli ProteinsLipopolysaccharidesBacterial Outer Membrane ProteinsBiological TransportCryoelectron MicroscopyCrystallography, X-RayGram-Negative BacteriaBacterial Outer Membrane ProteinsEscherichia coli ProteinsLipopolysaccharides

Identifiers

PMID35383177
PMCPMC8983717
OpenAlexW4224320274

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.